Welcome to our dedicated page for INTEST SEC filings (Ticker: INTT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on INTEST's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into INTEST's regulatory disclosures and financial reporting.
INTEST CORP director Karl E. Johnsen has filed a Form 3, which is an initial statement of beneficial ownership for insiders. This filing lists him as a director but does not report any share purchases, sales, or other transactions at this time.
INTEST CORP director Gerald J. Maginnis reported a disposition of 6,000 shares of Common Stock back to the company. This was recorded as a "Disposition to issuer" with a stated price of $0.00 per share. After the transaction, he directly holds 90,057 shares.
InTest Corporation held its 2026 Annual Meeting of Stockholders on June 17, 2026, where a quorum of 9,494,132 shares was present out of 12,548,356 shares outstanding as of the April 20, 2026 record date. Stockholders elected five directors to serve until the next annual meeting, each receiving a majority of votes cast. They also approved Amendment No. 1 to the InTest Corporation 2023 Stock Incentive Plan and ratified RSM US LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. In addition, stockholders approved, on an advisory basis, the compensation of the company’s named executive officers.
inTEST Corporation reported stronger results for the quarter ended March 31, 2026. Revenue rose to $33.9 million from $26.6 million a year earlier, driven across semiconductor, Auto/EV, defense/aerospace and life sciences markets. The company swung to net earnings of $0.8 million from a loss of $2.3 million, though operating cash flow moved to a use of $3.3 million from prior positive cash generation. Total assets were $150.8 million, including $12.9 million of cash and cash equivalents and $30.5 million of inventories. Share count remained stable, with 12.56 million common shares outstanding as of April 30, 2026.
InTest Corporation reported strong first quarter 2026 results with revenue of $33.9 million, up 27.2% year-over-year. Gross margin improved to 45.5%, and net earnings reached $0.8 million, or $0.06 per diluted share, compared with a loss a year ago. Non-GAAP adjusted EPS was $0.16 and adjusted EBITDA was $3.2 million, reflecting better volume, product mix and cost control.
Orders were $31.8 million, up 25.4% year-over-year, and backlog grew to $51.8 million, 35.5% higher than a year earlier. The company raised full-year 2026 revenue guidance to $130 million–$135 million and now expects about 45% gross margin and operating expenses of $55 million–$57 million. In a separate move, InTest amended its loan agreement with M&T Bank, extending the period to draw on its term loan facility to August 28, 2026.
inTEST Corp reports an institutional owner holding 681,913 shares. Vanguard Capital Management filed a Schedule 13G reporting 5.45% of the common stock, with sole dispositive power over 681,913 shares and sole voting power for 76,387 shares. The filing is signed by Ashley Grim on 04/30/2026.
inTest Corporation Schedule 13G/A: Thomas A. Satterfield, Jr. reports beneficial ownership of 550,000 shares of Common Stock, representing 4.4% of the class based on 12,495,544 shares outstanding as of February 27, 2026. The filing shows 40,000 shares with sole voting/dispositive power and 510,000 with shared voting/dispositive power. It discloses holdings held by related entities: Tomsat Investment & Trading Co., Inc. (80,000), A.G. Family L.P. (180,000), and Caldwell Mill Opportunity Fund, LLC (250,000). The form is signed by Mr. Satterfield on 04/29/2026.
INTEST CORP President and CEO Richard B. Rogoff reported a small share disposition tied to taxes rather than an open-market trade. On April 28, 2026, 220 shares of common stock at $16.90 per share were withheld to satisfy tax withholding obligations on vesting restricted stock.
After this tax-withholding disposition, Rogoff directly holds 11,932 shares of common stock. He also has multiple option grants and restricted stock units that give him additional potential exposure to INTEST CORP stock over the next several years as those awards vest or remain exercisable.
INTEST CORP Division President–Electronic Test, Joseph Richard McManus Jr., reported a routine tax-related share disposition. On April 28, 2026, 233 shares of common stock were withheld at $16.90 per share to cover tax obligations on vested restricted stock, leaving him with 35,460 common shares held directly. The filing also lists several employee stock options on common stock with exercise prices between $7.74 and $16.06 expiring from 2031 through 2036, which represent remaining derivative positions rather than new market transactions.